TABLE 2.
Peripheral blood |
Bone narrow |
||||||
---|---|---|---|---|---|---|---|
Mouse strain | Treatment | CD45 | CD45 | CD11c | CD11b | CD56 | CD3 |
SCID/Bg | no HSC | 0 | 0 | 0 | 0 | 0 | 0 |
NOD/SCID-γc−/− | no HSC | 0 | 0 | 0 | 0 | 0 | 0 |
SCID/Bg | HSC | 0.28±0.19 | 0.29±0.17 | 0 | 0.22±0.13 | 0 | 0 |
NOD/SCID-γc−/− | HSC | 28.41±29.60 | 56.9±22.30 | 32.66±21.30 | 2.76±2.05 | 1.89±0.77 | 0 |
Percentage of human CD markers on cells isolated from peripheral blood and bone marrow. Data represents averages and standard deviations.
HSC, hematopoietic stem cell; SCID/bg, severe combined immunodeficiency/beige; NOD, nonobese diabetic.